WASHINGTON (Reuters) – The U.S. Food and Drug Administration is focused on reviewing at-home and other COVID-19 tests, particularly those that can be manufactured at scale, Acting FDA Commissioner Janet Woodcock said at a Senate hearing on Tuesday.
(Reporting by Susan Heavey)
